Published on in Vol 10, No 8 (2021): August
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/31183, first published
.
Journals
- Bashir S, Uzair M, Abualait T, Arshad M, Khallaf R, Niaz A, Thani Z, Yoo W, Túnez I, Demirtas‑tatlidede A, Meo S. Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review). Molecular Medicine Reports 2022;25(4) View
- Li G, Li D, Wang T, He S. Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential. International Journal of Molecular Sciences 2021;22(19):10253 View
- Moussavi Z, Uehara M, Rutherford G, Lithgow B, Millikin C, Wang X, Saha C, Mansouri B, Omelan C, Fellows L, Fitzgerald P, Koski L. Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial. Neurotherapeutics 2024;21(3):e00331 View
- Saha C, Figley C, Lithgow B, Fitzgerald P, Koski L, Mansouri B, Anssari N, Wang X, Moussavi Z. Can Brain Volume-Driven Characteristic Features Predict the Response of Alzheimer’s Patients to Repetitive Transcranial Magnetic Stimulation? A Pilot Study. Brain Sciences 2024;14(3):226 View